China Shineway Pharmaceutical Group Limited (FRA:C1S)
Germany flag Germany · Delayed Price · Currency is EUR
0.8500
+0.0300 (3.66%)
At close: May 13, 2025, 10:00 PM CET

FRA:C1S Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
6,1405,8895,0264,2063,943
Upgrade
Short-Term Investments
4.484.023.694.325.32
Upgrade
Trading Asset Securities
350.022020.23--
Upgrade
Cash & Short-Term Investments
6,4955,9135,0504,2103,948
Upgrade
Cash Growth
9.84%17.08%19.96%6.63%-0.52%
Upgrade
Accounts Receivable
1,2021,260975.06825.18760.66
Upgrade
Other Receivables
66.8163.9267.4840.8723.07
Upgrade
Receivables
1,2691,3241,043866.05783.73
Upgrade
Inventory
813.19897.71657.66587.96443
Upgrade
Other Current Assets
2219.9432.0135.06343.99
Upgrade
Total Current Assets
8,5998,1556,7825,6995,519
Upgrade
Property, Plant & Equipment
1,2191,2051,2171,2521,395
Upgrade
Goodwill
165.96165.96165.96165.96102.5
Upgrade
Other Intangible Assets
23.3232.7947.3566.4336.96
Upgrade
Long-Term Deferred Tax Assets
34.3315.2319.2220.4723.1
Upgrade
Other Long-Term Assets
----137.14
Upgrade
Total Assets
10,0429,5748,2327,2047,214
Upgrade
Accounts Payable
402.96484.79308.75228.62164.38
Upgrade
Accrued Expenses
1,1991,121856.76483.21319.13
Upgrade
Short-Term Debt
330300--369.32
Upgrade
Current Portion of Leases
8.270.976.537.597.79
Upgrade
Current Income Taxes Payable
84.27105.91107.7965.158.37
Upgrade
Current Unearned Revenue
101.75127.4165.22117.0578.42
Upgrade
Other Current Liabilities
323.67294.13220.54196.81197.28
Upgrade
Total Current Liabilities
2,4502,4341,6661,0981,195
Upgrade
Long-Term Leases
8.260.360.917.3215.03
Upgrade
Long-Term Unearned Revenue
81.8588.89163.99171.59204.31
Upgrade
Long-Term Deferred Tax Liabilities
34.5216.2618.8425.195.3
Upgrade
Total Liabilities
2,5752,5391,8491,3021,419
Upgrade
Common Stock
87.6687.6687.6687.6687.66
Upgrade
Additional Paid-In Capital
422.14422.14422.14422.14422.14
Upgrade
Retained Earnings
7,4527,0206,3685,8795,778
Upgrade
Comprehensive Income & Other
-494.89-494.89-494.89-487.32-493.42
Upgrade
Total Common Equity
7,4677,0356,3835,9015,794
Upgrade
Shareholders' Equity
7,4677,0356,3835,9015,794
Upgrade
Total Liabilities & Equity
10,0429,5748,2327,2047,214
Upgrade
Total Debt
346.53301.337.4414.91392.14
Upgrade
Net Cash (Debt)
6,1485,6115,0434,1953,556
Upgrade
Net Cash Growth
9.56%11.28%20.21%17.97%-0.23%
Upgrade
Net Cash Per Share
8.147.436.685.564.70
Upgrade
Filing Date Shares Outstanding
755.4755.4755.4755.4754.6
Upgrade
Total Common Shares Outstanding
755.4755.4755.4755.4754.6
Upgrade
Working Capital
6,1495,7215,1174,6014,324
Upgrade
Book Value Per Share
9.889.318.457.817.68
Upgrade
Tangible Book Value
7,2786,8366,1695,6695,655
Upgrade
Tangible Book Value Per Share
9.639.058.177.507.49
Upgrade
Machinery
1,4941,4891,4381,3921,388
Upgrade
Construction In Progress
195.51117.68193.06130.17115.5
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.